Literature DB >> 11948070

Cardiac inflammation and innate immunity in septic shock: is there a role for toll-like receptors?

Pascal Knuefermann1, Shintaro Nemoto, Georg Baumgarten, Arunima Misra, Natarajan Sivasubramanian, Blasé A Carabello, Jesus G Vallejo.   

Abstract

Our current understanding of the pathogenesis of sepsis suggests that bacteria as well as bacterial-derived products activate an uncontrolled network of host-derived mediators such as proinflammatory cytokines (ie, tumor necrosis factor [TNF] and interleukin [IL]-1beta), which can ultimately lead to cardiovascular collapse and death. Despite the potentially important role that TNF and IL-1beta may play in producing cardiac dysfunction in human septic shock, little is known with regard to the basic biochemical mechanism(s) by which bacterial pathogens induce their expression in the heart. A major advance in understanding the early events that are downstream from bacterial-mediated signaling has been the identification of Toll-like receptors (TLRs). TLR-mediated signaling is known to activate the transcription factor nuclear factor-kappaB and to upregulate TNF expression. It has recently been shown that the heart expresses TLRs, raising the possibility that these receptors may be responsible for mediating the deleterious effects of bacterial pathogens on cardiac function. In this review, we will discuss the emerging role for TLRs in the pathogenesis of the cardiovascular collapse that occurs during sepsis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11948070     DOI: 10.1378/chest.121.4.1329

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  16 in total

1.  Toll-like receptor 4 signaling confers cardiac protection against ischemic injury via inducible nitric oxide synthase- and soluble guanylate cyclase-dependent mechanisms.

Authors:  E Wang; Yan Feng; Ming Zhang; Lin Zou; Yan Li; Emmanuel S Buys; Peigen Huang; Peter Brouckaert; Wei Chao
Journal:  Anesthesiology       Date:  2011-03       Impact factor: 7.892

2.  Selective impairment of nuclear factor-kappaB-dependent gene transcription in adult cardiomyocytes: relevance for the regulation of the inflammatory response in the heart.

Authors:  Jimena Cuenca; Nora Goren; Patricia Prieto; Paloma Martín-Sanz; Lisardo Boscá
Journal:  Am J Pathol       Date:  2007-08-03       Impact factor: 4.307

3.  Synthesis and Evaluation of Conjugates of Novel TLR7 Inert Ligands as Self-Adjuvanting Immunopotentiators.

Authors:  Dong Gao; Yu Liu; Yuwen Diao; Ningning Gao; Zhulin Wang; Wenqi Jiang; Guangyi Jin
Journal:  ACS Med Chem Lett       Date:  2015-01-30       Impact factor: 4.345

4.  The differential diagnostic value of serum NT-proBNP in hospitalized patients of heart failure with pneumonia.

Authors:  Shuangshuang Yang; Linbin Li; Ju Cao; Hongsong Yu; Huajian Xu
Journal:  J Clin Lab Anal       Date:  2014-03-28       Impact factor: 2.352

Review 5.  TNFα in myocardial ischemia/reperfusion, remodeling and heart failure.

Authors:  Petra Kleinbongard; Rainer Schulz; Gerd Heusch
Journal:  Heart Fail Rev       Date:  2011-01       Impact factor: 4.214

6.  Genetic predisposition to Helicobacter pylori-induced gastric precancerous conditions.

Authors:  Asahi Hishida; Keitaro Matsuo; Yasuyuki Goto; Nobuyuki Hamajima
Journal:  World J Gastrointest Oncol       Date:  2010-10-15

7.  The effect of lysophosphatidic acid on Toll-like receptor 4 expression and the nuclear factor-κB signaling pathway in THP-1 cells.

Authors:  Bo Yang; Zhibin Zhou; Xiaohao Li; Jianping Niu
Journal:  Mol Cell Biochem       Date:  2016-09-13       Impact factor: 3.396

8.  Association between Toll-like receptor 4 and interleukin 17 gene polymorphisms and colorectal cancer susceptibility in Northeast China.

Authors:  Lin Zhu; Yibaina Wang; Ge Jie; Qiang Chi; Junde Zhou; Binbin Cui; Daxun Piao; Yashuang Zhao
Journal:  Med Oncol       Date:  2014-09-13       Impact factor: 3.064

9.  Immunotherapeutic activity of a conjugate of a Toll-like receptor 7 ligand.

Authors:  Christina C N Wu; Tomoko Hayashi; Kenji Takabayashi; Mojgan Sabet; Donald F Smee; Donald D Guiney; Howard B Cottam; Dennis A Carson
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-21       Impact factor: 11.205

10.  Sitagliptin attenuates inflammatory responses in lipopolysaccharide-stimulated cardiomyocytes via nuclear factor-κB pathway inhibition.

Authors:  Chien-Hung Lin; Chung-Ching Lin
Journal:  Exp Ther Med       Date:  2016-04-11       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.